Furfenorex
Furfenorex (Frugalan), also known as furfurylmethylamphetamine, is a stimulant drug which was developed in the 1960s and used as an appetite suppressant.[1] It produces methamphetamine as a metabolite,[2] and has been withdrawn from the market due to abuse potential.[3]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H19NO |
Molar mass | 229.317 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
References
- Boissier, JR; Dumont, C; Ratouis, R; Moisy, D (1967). "Pharmacologic study of an anorexigenic agent: furfenorex". Archives Internationales de Pharmacodynamie et de Thérapie. 167 (1): 150–62. PMID 6035092.
- Marsel, J; Döring, G; Remberg, G; Spiteller, G (1972). "Methamphetamine--a metabolite of the anorectics Benzphetamine and Furfenorex". Zeitschrift für Rechtsmedizin. 70 (4): 245–50. doi:10.1007/BF02079690. PMID 5084766.
- Daspaguta, Amitava (March 2009). A Health Educator’s Guide to Understanding Drugs of Abuse Testing (1 ed.). Sudbury, Massachusetts: Jones & Bartlett Publishers. ISBN 9780763765897. Retrieved 11 December 2019.
DRAs |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NRAs |
| ||||||||||||||
SRAs |
| ||||||||||||||
Others |
| ||||||||||||||
See also: Receptor/signaling modulators • Monoamine reuptake inhibitors • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins |
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.